To substantiate these findings, a luciferase reporter gene assay was conducted, revealing that derivative 4F effectively reduced Rac1 promoter activity in BC cells in a dose-dependent manner, accompanied by a dose-dependent downregulation of Rac1 protein expression. This evidence concerns the gene RAC1 and breast cancer.